New potential RCC entities include papillary renal neoplasm with reversed polarity (PRNRP) and biphasic hyalinizing psammomatous RCC (BHP RCC), which have distinct driver mutations (KRAS and NF2, respectively) [96,97,98,99]. Here, KRAS is linked to renal cell carcinoma.